
Paradigms, Policy and Pharmacogenomics: What community oncologists need to know
The evolution of cancer care is advancing so quickly, it’s nearly impossible to keep up. Genetic sequencing has radically improved our ability to get the right drug to the right patient—improving outcomes for both patients and practices. But policy is unclear, lab testing is interpreted differently, and funding is available—but how do you get it?
In this episode, we are joined by Dr. Howard McLeod (internationally recognized expert in precision medicine and medical director for precision medicine at the Geriatric Oncology Consortium) and Dr. Jai Patel (chair of the department of cancer…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.